OS Therapies names Chief Medical Advisor Craig Eagle to board

OS Therapies Incorporated

OS Therapies Incorporated

OSTX

0.00
  • OS Therapies appointed Chief Medical Advisor Craig Eagle to its board, replacing departing director Karim Galzahr, who will remain on the advisory board.
  • Eagle previously served as chief medical officer at Guardant Health.
  • Earlier roles included vice president of medical affairs oncology at Genentech, with prior oncology leadership positions at Pfizer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607020730NEWSFILECNPR____20260702_303725_1) on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.